Compound Detail
CHEMBL51149
GALLOPAMIL 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL51149 |
| Name | GALLOPAMIL |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | XQLWNAFCTODIRK-UHFFFAOYSA-N |
7
Targets
18
Activities
3
Assay Types
0
PK Parameters
20
Publications
5
Known Names
2
Indications
Molecular Properties
484.6
MW (Da)
5.10
ALogP
7
HBA
0
HBD
73.2
PSA (Ų)
0.37
QED
1
Ro5 Violations
14
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Indications
Asthma Cardiovascular Diseases
ATC Classification
C08DA02
gallopamil
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CALCIUM CHANNEL BLOCKERS
Activity Summary
IC50 11 meas. best 7.96
Ki 4 meas. best 8.27
EC50 3 meas. best 7.66
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Voltage-gated L-type calcium channel CHEMBL2095229 | Ki | 8.27 | 8.27 | 5.4 | 1 |
| Voltage-gated L-type calcium channel CHEMBL2095229 | IC50 | 7.96 | 7.96 | 11.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.82 | 7.612 | 15.0 | 5 |
| Unchecked CHEMBL612545 | Ki | 7.81 | 7.72 | 15.5 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C CHEMBL1940 | IC50 | 7.77 | 7.77 | 17.0 | 1 |
| Rattus norvegicus CHEMBL376 | EC50 | 7.66 | 7.01 | 21.8 | 3 |
| Voltage-gated L-type calcium channel CHEMBL2095177 | IC50 | 7.64 | 7.64 | 23.0 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 6.47 | 6.47 | 342.0 | 1 |
| ATP-dependent translocase ABCB1 CHEMBL4302 | IC50 | 5.5 | 5.5 | 3200.0 | 1 |
| Sodium channel alpha subunits; brain (Types I, II, III) CHEMBL2096682 | IC50 | 5.44 | 5.44 | 3600.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 2B | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Nuclear receptor subfamily 1 group I member 2 | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M2 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-2 adrenergic receptor | 2 |
| 23466604 | 10.1016/j.ejmech.2013.01.044 | Voltage-gated L-type calcium channel | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Gamma-aminobutyric acid receptor subunit alpha-1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Androgen receptor | 2 |
| 2579237 | 10.1021/jm00381a019 | Sodium channel alpha subunits; brain (Types I, II, III) | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Beta-1 adrenergic receptor | 2 |
| 18983139 | 10.1021/jm8007618 | Unchecked | 2 |
| 2427721 | 10.1021/jm00159a040 | Rattus norvegicus | 2 |
| 6304312 | 10.1021/jm00360a001 | Oryctolagus cuniculus | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | 5-hydroxytryptamine receptor 1A | 2 |
| 6304312 | 10.1021/jm00360a001 | Canis familiaris | 2 |
| 2153831 | 10.1021/jm00164a064 | Unchecked | 2 |
Data from ChEMBL 36 via Core Engine